Next Article in Journal
The Right Treatment Strategy for the Right Patient: A Biomarker-Driven Approach to Neoadjuvant vs. Surgery-First Management of Resectable and Borderline Resectable Pancreatic Cancer
Previous Article in Journal
Comparison of Side Effects of Nalbuphine and Morphine in the Treatment of Pain in children with Cancer: A Prospective Study
Previous Article in Special Issue
Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations
 
 
Article

Article Versions Notes

Cancers 2022, 14(15), 3619; https://doi.org/10.3390/cancers14153619
Action Date Notes Link
article xml file uploaded 25 July 2022 16:03 CEST Original file -
article xml uploaded. 25 July 2022 16:03 CEST Update https://www.mdpi.com/2072-6694/14/15/3619/xml
article pdf uploaded. 25 July 2022 16:03 CEST Version of Record https://www.mdpi.com/2072-6694/14/15/3619/pdf
article html file updated 25 July 2022 16:04 CEST Original file -
article html file updated 13 August 2022 03:39 CEST Update https://www.mdpi.com/2072-6694/14/15/3619/html
Back to TopTop